Dan Scavilla had been chief executive of Dentsply Sirona for just under seven months when he told analysts on Feb. 26 that the company would stop paying shareholders.
“Following a strategic review, we have eliminated our dividend,” Scavilla said on the company’s fourth-quarter earnings call. “I want to emphasize that this decision reflects an assessment of an optimal capital deployment strategy and feedback from many of our shareholders.”
The money would go to paying down debt and buying back stock. On the same call, Scavilla announced a restructuring program, confirmed the wind-down of Byte, its direct-to-consumer aligner business, and described what the next stretch would look like. “This is not a short-term reset,” he said. “It is a focused transformation built on going deeper, moving faster, and being bolder.”
Seven months after that call, the company has a new chief financial officer, a rebuilt set of U.S. dealer relationships, a quarter back in the black and a stock that Armistice Capital, the New York hedge fund, continues to hold.
A Globus Veteran Arrives
Dentsply Sirona’s board named Scavilla chief executive on July 21, 2025, effective Aug. 1. He replaced Simon Campion, who had led the Charlotte, North Carolina-based dental products maker for three years.
Scavilla came from Globus Medical, the spine and orthopedic device company, where he had served as chief financial officer, chief commercial officer and then president and CEO, and where he led the roughly $3 billion acquisition of NuVasive. Before Globus, he spent 28 years at Johnson & Johnson in finance and operating roles, including as CFO of its Advanced Sterilization Products business, the company said.
“Dan is a seasoned healthcare veteran, and we’re confident that his three decades of executive leadership experience and disciplined focus on commercial growth, product innovation and financial and operational excellence make him well-suited to lead the Company into its next chapter,” said Gregory T. Lucier, the board’s chair.
Campion’s departing statement was brief. “It has been a privilege to serve as CEO over the past three years,” he said. “While we have had to address a number of challenges, Dentsply Sirona now has a strong foundation in place, and I fully expect the Company will reach new heights under Dan’s leadership.”
One of those challenges was Byte. Dentsply had suspended sales of Byte’s at-home aligner systems and impression kits in late 2024, and in January 2025, under Campion, it said it would not reinstate them and would instead rebuild the business around treatment with more in-person dentist oversight. When Scavilla presented his first full-year results, the plan had narrowed further. “As we wind down the Byte business in 2026, income from Byte will not recur and will represent a headwind going forward,” Mike Popperoy, then interim chief financial officer, told analysts in February. Byte had contributed about 13 cents a share of income in 2025, he said.
Rebuilding the Sales Channel
The first large commercial move of Scavilla’s tenure came before the February plan. On Jan. 13, Dentsply and Benco Dental, a distributor that had sold Dentsply’s consumables for decades, announced that Benco would begin selling the company’s equipment too.
The list covered most of Dentsply’s technology business: CEREC chairside milling systems and the blocks they use, Primescan and Primescan 2 intraoral scanners, and Axeos and Orthophos extraoral imaging units. Benco said it would display the equipment at three showrooms it calls CenterPoints, near Los Angeles, near Dallas and between New York City and Philadelphia.
“For our customers, this partnership means easier access to cutting-edge digital solutions supported by the expert, fast, and reliable service they’ve come to expect from Benco Dental,” said Katy Cohen, Benco’s president.
More agreements followed. Scavilla told analysts in February that Dentsply had signed new or expanded deals with Benco, Patterson, Burkhart and A-dec. Dentsply added Atlanta Dental Supply in the first quarter and installed its first CEREC system through Benco, according to its May results. By August, Nashville Dental and Medline Sinclair in Canada had joined, and Scavilla told analysts that two of the new dealers had grown by double digits so far.
The February Plan
The Feb. 26 announcement put numbers to the approach. Scavilla said the restructuring program would “streamline functions, improve efficiency, and support a more competitive cost structure.”
“The program is expected to unlock approximately $120 million annually across the P&L, which will be reinvested in the Return to Growth action plan,” Scavilla said on the call. The company expected $55 million to $65 million in one-time charges, most of them paid in 2026 and 2027.
Full-year 2025 sales had come to $3.68 billion, down 4.3% in constant currency, with Byte accounting for 1.9 percentage points of that decline. For 2026, Dentsply guided to net sales of $3.5 billion to $3.6 billion and adjusted earnings of $1.40 to $1.50 a share.
Armistice Capital, whose website lists an office at 510 Madison Avenue in New York, reported Dentsply shares in its filings for both the fourth quarter of 2025 and the first quarter of 2026.
A Loss, Then a Profit
The first quarter under the plan was the hardest to read. Reported net sales were essentially flat at $880 million, but in constant currency they fell 6.7%. Dentsply lost $10 million, or 5 cents a share, compared with a $20 million profit a year earlier. Adjusted earnings per share fell to 27 cents from 44 cents, and adjusted EBITDA margin slid to 14.7% from 19%.
“While near-term performance is impacted by external pressures and investment timing, we are making solid progress toward sustainable growth,” Scavilla said in the May 5 release. “During the quarter, we advanced our commercial restructuring and continued portfolio innovation, with early traction from distributor partners. We remain confident in our strategy, maintain our full-year outlook, and expect momentum to build throughout the year.”
The quarter had other markers. Operating cash flow rose to $40 million from $7 million a year earlier. Dentsply also launched Smart View-Detect, which it described as “the world’s first FDA-cleared, AI-enabled diagnostic aid designed to identify teeth with periapical radiolucencies (PARL) in CBCT scans,” and said the tool had also been CE-marked for use in Europe. The company held its full-year outlook.
Five weeks later, the finance seat was filled. Dentsply named John Fortson chief financial officer on June 11, effective July 20. Fortson had been president and CFO of Kymera International, and before that spent nearly a decade at Ingevity, first as CFO and treasurer and later as president and CEO. He was also CFO of AAR Corp., spent 15 years as an investment banker, most recently as a managing director at Bank of America Merrill Lynch, and served seven years as a U.S. Army officer.
“I am honored to join Dentsply Sirona at such an important time for the Company,” Fortson said in the announcement.
His first earnings call came 17 days after he started. The second quarter showed a $37 million profit, compared with a $45 million loss a year earlier, on sales of $898 million, down 6.3% in constant currency. A $44 million tariff refund contributed 17 cents a share, Fortson told analysts. Stripping out Byte and a planned reduction in dealer inventory, constant-currency sales fell 3.6%, Fortson said, according to a Yahoo Finance summary of the call. Operating cash flow more than doubled to $99 million. Dentsply bought back 1.3 million shares for about $12 million, and total debt fell to $2.224 billion from $2.328 billion at the end of 2025.
Armistice Through the Change
Armistice held Dentsply stock throughout the first half of 2026. The fund reported 7,298,000 Dentsply shares, worth about $83.4 million, at the end of 2025, according to its 13F filings as compiled by 13f.info. At March 31, the stake stood at 3 million shares worth $34.8 million. Armistice added 672,000 shares during the second quarter, bringing the total to 3,672,000, worth about $39 million.
Measured against the whole June filing, which listed 333 positions worth $8.17 billion, Dentsply made up about half of 1%. Index put options on the SPY and IWM funds sat at the top of that list, ahead of Madrigal Pharmaceuticals and Cytokinetics call options.
Other Dentsply holders tracked by GuruFocus include John Rogers of Ariel Investments, who reported 8,026,107 shares at the end of June, or about 4% of shares outstanding, and First Eagle Investment Management, which held 1,702,694. GuruFocus also noted that the Ariel Focus Fund added to its position at $10.61 a share.
What the Plan Still Has to Deliver
The measurable parts of the turnaround are now on a calendar. Dentsply has to realize the $120 million in annual savings it promised in February. It has to hit sales of $3.5 billion to $3.6 billion and adjusted earnings of $1.40 to $1.50 a share, and its guidance excludes further tariff refunds. The Byte wind-down continues through 2026, and the income that business once produced is gone.
The dealer expansion has the shortest record. Dentsply signed or widened agreements with Benco, Patterson, Burkhart, A-dec, Atlanta Dental Supply, Nashville Dental and Medline Sinclair between January and August. The third quarter will also be Fortson’s first full quarter as CFO.
Sources
- Dentsply Sirona, “Dentsply Sirona Appoints Daniel Scavilla as Chief Executive Officer” (July 21, 2025): https://www.globenewswire.com/news-release/2025/07/21/3118712/0/en/Dentsply-Sirona-Appoints-Daniel-Scavilla-as-Chief-Executive-Officer.html
- MassDevice, “Dentsply Sirona suspends sales and marketing for Byte aligners” (Oct. 25, 2024): https://www.massdevice.com/dentsply-suspends-sales-marketing-byte-aligners/
- Dentsply Sirona, “Dentsply Sirona Announces Repositioning of Byte within Aligner Portfolio” (Jan. 14, 2025): https://investor.dentsplysirona.com/news-releases/news-release-details/dentsply-sirona-announces-repositioning-byte-within-aligner
- Dentsply Sirona and Benco Dental, “Dentsply Sirona and Benco Dental Announce Expanded Partnership to Include Dental Technology Solutions” (Jan. 13, 2026): https://www.globenewswire.com/news-release/2026/01/13/3218291/0/en/Dentsply-Sirona-and-Benco-Dental-Announce-Expanded-Partnership-to-Include-Dental-Technology-Solutions.html
- The Motley Fool, “DENTSPLY SIRONA (XRAY) Q4 2025 Earnings Transcript” (Feb. 26, 2026): https://www.fool.com/earnings/call-transcripts/2026/02/26/dentsply-sirona-xray-q4-2025-earnings-transcript/
- Dentsply Sirona, “Dentsply Sirona Reports Fourth Quarter and Full Year 2025 Results, Provides Full Year 2026 Outlook” (Feb. 26, 2026): https://www.globenewswire.com/news-release/2026/02/26/3246054/0/en/Dentsply-Sirona-Reports-Fourth-Quarter-and-Full-Year-2025-Results-Provides-Full-Year-2026-Outlook.html
- Dentsply Sirona, “Dentsply Sirona Reports First Quarter 2026 Results” (May 5, 2026): https://www.globenewswire.com/news-release/2026/05/05/3288198/0/en/dentsply-sirona-reports-first-quarter-2026-results.html
- Dentsply Sirona, “Dentsply Sirona Appoints John Fortson as Chief Financial Officer” (June 11, 2026): https://www.globenewswire.com/news-release/2026/06/11/3310453/0/en/Dentsply-Sirona-Appoints-John-Fortson-as-Chief-Financial-Officer.html
- Dentsply Sirona, “Dentsply Sirona Reports Second Quarter 2026 Results” (Aug. 6, 2026): https://www.globenewswire.com/news-release/2026/08/06/3340684/0/en/dentsply-sirona-reports-second-quarter-2026-results.html
- Dentsply Sirona (XRAY) Q2 2026 Earnings Call Transcript, via AOL: https://www.aol.com/articles/dentsply-sirona-xray-q2-2026-044509000.html
- Yahoo Finance, “DENTSPLY SIRONA Q2 Earnings Call Highlights”: https://finance.yahoo.com/markets/stocks/articles/dentsply-sirona-q2-earnings-call-210417737.html
- info, Armistice Capital Q4 2025 13F holdings: https://13f.info/13f/000131586326000163-armistice-capital-llc-q4-2025
- info, Armistice Capital Q1 2026 13F holdings: https://13f.info/13f/000131586326000414-armistice-capital-llc-q1-2026
- info, Armistice Capital Q2 2026 13F holdings: https://13f.info/13f/000131586326000589-armistice-capital-llc-q2-2026
- GuruFocus, Dentsply Sirona guru holdings: https://www.gurufocus.com/stock/XRAY/guru-trades












Comments